Female patients in clinical studies were found to be more susceptible than male patients to gastrointestinal adverse reactions and weight loss.
Kliinilistes uuringutes esines naispatsientidel sagedamini seedetrakti häireid ja kehakaalu vähenemist kui meespatsientidel.